Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine

Vaccination of pigs may curtail Taenia solium transmission by reducing the number of cysticerci, the precursors of adult intestinal tapeworms in humans. Several antigen preparations induce protection against porcine cysticercosis in experimental settings but only one subunit vaccine (S3Pvac) has bee...

Descripción completa

Detalles Bibliográficos
Autores: Sciutto, Edda, Rosas, Gabriela, Hernández, Marisela, Morales, Julio, Cruz Revilla, Carmen, Toledo, Andrea, Manoutcharian, Karen, Gevorkian, Goar, Blancas, Abel, Acero, Gonzalo, Hernández, Beatriz, Cervantes, Jacquelynne, Bobes, Raul J., Goldbaum, Fernando Alberto, Huerta, Mirna, Diaz Orea, Alicia, Fleury, Agnes, de Aluja, Aline S., Cabrera Ponce, José Luis, Herrera Estrella, Luis, Fragoso, Gladis, Larralde, Carlos
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2006
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/28060
Acceso en línea:http://hdl.handle.net/11336/28060
Access Level:acceso abierto
Palabra clave:Cysticercosis
Vaccine
Bls
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
Descripción
Sumario:Vaccination of pigs may curtail Taenia solium transmission by reducing the number of cysticerci, the precursors of adult intestinal tapeworms in humans. Several antigen preparations induce protection against porcine cysticercosis in experimental settings but only one subunit vaccine (S3Pvac) has been tested and proved effective in the field against naturally acquired disease. Besides improving of the vaccine's effectiveness, significant reductions in production costs and in the logistics of its administration are necessary for the feasibility of nationwide control programs. This review highlights the development of several versions of S3Pvac aimed to increase effectiveness, reduce costs and increase feasibility by novel delivery systems and alternative routes of administration